Gunter von Minckwitz, MD, on the Phase III ICE Trial
2014 San Antonio Breast Cancer SymposiumGunter von Minckwitz, MD, of the University of Frankfurt, offers his thoughts on abstract S3-04, "The phase III ICE study: Adjuvant ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer."
Related Videos
Clifford A. Hudis, MD, FACP, on the SOFT Trial
Clifford A. Hudis, MD, FACP, of Memorial Sloan Kettering Cancer Center, discusses findings from abstract S3-08,
Lisa A. Carey, MD, of the UNC Lineberger Comprehensive Cancer Center, addresses further analysis of data from abstract S4-05,
William M. Sikov, MD, of Women and Infants Hospital, discusses abstract S4-05, ...
Lisa A. Carey, MD, on the CALGB/Alliance 40603 Trial
William M. Sikov, MD, on the CALGB 40603 Trial
Ian E. Krop, MD, PhD, on Pictilisib in Metastatic Breast Cancer
Ian E. Krop, MD, PhD, of Dana-Farber Cancer Institute, discusses abstract S2-02,
Larry Wickerham, MD, and Charles E. Geyer, Jr., MD, FACP, on Results from NSABP B-36 and SOFT Trials
Larry Wickerham, MD, and Charles E. Geyer, Jr., MD, FACP, take a closer look at the results from the NSABP B-36 and SOFT Trials.
